Misoprostol for Reduction of Blood Loss During Fibroid Surgery
Buccal Misoprostol Prior to Abdominal Myomectomy for Reduction of Intraoperative Blood Loss: A Randomized Placebo-Controlled Trial
Sponsor: Northwestern University
Terminated
The study was prematurely closed due to low enrollment rates.
Other terminated trials from Northwestern University
Other Fibroids trials with similar outcome
This PHASE4 trial investigates Fibroids and is currently terminated or withdrawn. Northwestern University leads this study, which shows 14 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Mar 2023 — Oct 2023 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2022 — Mar 2023 [monthly]
Recruiting PHASE4
▶ Show 9 earlier versions
-
Apr 2021 — Jan 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE4
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
May 2019 — Mar 2020 [monthly]
Recruiting PHASE4
-
Aug 2018 — May 2019 [monthly]
Recruiting PHASE4
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Northwestern University
For direct contact, visit the study record on ClinicalTrials.gov .